Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio Culture
Investing in People: Why DeciBio's Offsites Are Our Secret Weapon
How DeciBio's unique offsite approach drives success.
November 27, 2024
DeciBio Culture
Investing in People: Why DeciBio's Offsites Are Our Secret Weapon
How DeciBio's unique offsite approach drives success.
November 27, 2024
DeciBio News
Life Science Consulting
Blog Article
Pharma & Biotech
SABCS 2024: Leveraging Advanced GenAI Pipelines to Decode 3,000 Pages of Abstracts
When the San Antonio Breast Cancer Symposium released their abstracts booklet, our team jumped right in. Using our advanced Generative AI powered pipelines, we processed and analyzed all that information for our clients within just one hour of release!
November 26, 2024
Blog Article
Pharma & Biotech
SABCS 2024: Leveraging Advanced GenAI Pipelines to Decode 3,000 Pages of Abstracts
When the San Antonio Breast Cancer Symposium released their abstracts booklet, our team jumped right in. Using our advanced Generative AI powered pipelines, we processed and analyzed all that information for our clients within just one hour of release!
November 26, 2024
AI / Machine Learning
.png)
DeciBio Q&A
Financial Services
AI-Powered Drug Discovery and Antibody Innovation: DeciBio Q&A with Sean McClain, Founder & CEO, and Zach Jonasson, CFO & CBO at Absci
In this DeciBio Q&A, Sean McClain, Founder & CEO of Absci, and Zach Jonasson, CFO & CBO, dive into the transformative role of AI in drug discovery, emphasizing Absci’s mission to tackle undruggable targets through generative AI antibody design.
November 21, 2024
DeciBio Q&A
Financial Services
AI-Powered Drug Discovery and Antibody Innovation: DeciBio Q&A with Sean McClain, Founder & CEO, and Zach Jonasson, CFO & CBO at Absci
In this DeciBio Q&A, Sean McClain, Founder & CEO of Absci, and Zach Jonasson, CFO & CBO, dive into the transformative role of AI in drug discovery, emphasizing Absci’s mission to tackle undruggable targets through generative AI antibody design.
November 21, 2024
AI / Machine Learning
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | October Round-Up 2024
Liquid Biopsy (LBx) continued to develop through October, featuring new FDA approvals and fundraising.
November 12, 2024
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | October Round-Up 2024
Liquid Biopsy (LBx) continued to develop through October, featuring new FDA approvals and fundraising.
November 12, 2024
Liquid Biopsy
DeciBio Q&A
Financial Services
Navigating Biotech Investment and Innovation: AI and the Future of Health with Uplaksh Kumar, COO at Foresite Labs and Venture Partner at Foresite Capital
We recently interviewed Uplaksh Kumar, COO at Foresite Labs and Venture Partner at Foresite Capital, a multi-stage healthcare and life sciences investment firm.
November 7, 2024
DeciBio Q&A
Financial Services
Navigating Biotech Investment and Innovation: AI and the Future of Health with Uplaksh Kumar, COO at Foresite Labs and Venture Partner at Foresite Capital
We recently interviewed Uplaksh Kumar, COO at Foresite Labs and Venture Partner at Foresite Capital, a multi-stage healthcare and life sciences investment firm.
November 7, 2024
AI / Machine Learning
DeciBio Ventures
.png)
Newsletter Update
Clinical Diagnostics
Digital Health and Informatics - October Roundup
October 2024 saw several exciting updates, advancements, and partnerships in digital health and informatics.
November 7, 2024
Newsletter Update
Clinical Diagnostics
Digital Health and Informatics - October Roundup
October 2024 saw several exciting updates, advancements, and partnerships in digital health and informatics.
November 7, 2024
Digital Health
Health Technology Market
Women's Health
Medical Devices
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved